Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Development of carboxylated multi-walled carbon nanotubes and bovine serum albumin reinforced hydroxyapatite for bone substitute applications

Development of carboxylated multi-walled carbon nanotubes and bovine serum albumin reinforced... The similarity of the chemical composition of hydroxyapatite (HA) to the mineral phase of bone and their excellent biocompatibility meets the requirement of materials designed for bone repair and augmentation purposes. However, the application of HA in load-bearing devices is limited by its poor mechanical properties. Carbon nanotubes (CNTs), with their outstanding stiffness and strength, have good potential applications in tissue engineering. These properties, combined with their small size and large interfacial area, suggest that they may have great potential as a reinforcing agent for HA. The hydroxyapatite/multi-walled carbon nanotubes/bovine serum albumin (HA/MWCNTs-COOH/BSA) with particle size in the range 20 to 25 nm composites was successfully produced using precipitation technique. The compressive strength of heat-treated composites at 600 to 1000 °C is in the range between 27 and 37 MPa. The cytotoxic effect of the composites with different concentrations was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT assay) against normal human colon fibroblast. The developed composites were found to be non-cytotoxic when treated to the human fibroblast cells and imply a proliferative effect on cells. The developed composites are possibly a good choice to use as non-toxic material for bone substitution at the level of the trabecular bone. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the Australian Ceramic Society Springer Journals

Development of carboxylated multi-walled carbon nanotubes and bovine serum albumin reinforced hydroxyapatite for bone substitute applications

Loading next page...
 
/lp/springer-journals/development-of-carboxylated-multi-walled-carbon-nanotubes-and-bovine-9bcC0nPDmI
Publisher
Springer Journals
Copyright
Copyright © 2016 by Australian Ceramic Society
Subject
Materials Science; Ceramics, Glass, Composites, Natural Materials; Materials Engineering; Inorganic Chemistry
ISSN
2510-1560
eISSN
2510-1579
DOI
10.1007/s41779-016-0016-4
Publisher site
See Article on Publisher Site

Abstract

The similarity of the chemical composition of hydroxyapatite (HA) to the mineral phase of bone and their excellent biocompatibility meets the requirement of materials designed for bone repair and augmentation purposes. However, the application of HA in load-bearing devices is limited by its poor mechanical properties. Carbon nanotubes (CNTs), with their outstanding stiffness and strength, have good potential applications in tissue engineering. These properties, combined with their small size and large interfacial area, suggest that they may have great potential as a reinforcing agent for HA. The hydroxyapatite/multi-walled carbon nanotubes/bovine serum albumin (HA/MWCNTs-COOH/BSA) with particle size in the range 20 to 25 nm composites was successfully produced using precipitation technique. The compressive strength of heat-treated composites at 600 to 1000 °C is in the range between 27 and 37 MPa. The cytotoxic effect of the composites with different concentrations was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (MTT assay) against normal human colon fibroblast. The developed composites were found to be non-cytotoxic when treated to the human fibroblast cells and imply a proliferative effect on cells. The developed composites are possibly a good choice to use as non-toxic material for bone substitution at the level of the trabecular bone.

Journal

Journal of the Australian Ceramic SocietySpringer Journals

Published: Dec 20, 2016

References